Gondi Kumar

5.6k citations

53 papers · 2.5k indexed · h-index 24

Impact in

Virology top 1%
- HIV Research and Treatment
Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism

Papers in ⓘ

Oncology 25
- Cancer Treatment and Pharmacology 13
- Drug Transport and Resistance Mechanisms 9
Molecular Biology 20
- Protein Degradation and Inhibitors 4

Co-authors: Sekhar Surapaneni (13 shared papers)Jon F. Denissen (6 shared papers)Thomas Walle (9 shared papers)U. Kristina Walle (6 shared papers)A. David Rodrigues (2 shared papers)Alex Buko (1 shared paper)Kapil N. Bhalla (5 shared papers)Henry Lau (3 shared papers)
Journals: Drug Metabolism and Disposition (11 papers)Cancer Chemotherapy and Pharmacology (8 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Xenobiotica (3 papers)
Partner nations: United States Switzerland United Kingdom

In The Last Decade

Gondi Kumar

52 papers receiving 2.4k citations

Peers

Countries citing papers authored by Gondi Kumar

Since Specialization

Citations

This map shows the geographic impact of Gondi Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gondi Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gondi Kumar more than expected).

Fields of papers citing papers by Gondi Kumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gondi Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gondi Kumar. The network helps show where Gondi Kumar may publish in the future.

Co-authors

The 25 scholars most cited alongside Gondi Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gondi Kumar Line = papers co-authored together Gondi Kumar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir Antimicrobial Agents and Chemotherapy ·Dale J. Kempf, Kennan C. Marsh, Gondi Kumar, A. David Rodrigues, Jon F. Denissen, Edith McDonald, Michael Kukulka, Ann Hsu, G. Richard Granneman, Paolo Baroldi, Eugene Sun, David Pizzuti, J. J. PLATTNER, Daniel W. Norbeck, John M. Leonard	1997	310
2	Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes. Journal of Pharmacology and Experimental Therapeutics ·Gondi Kumar, A. David Rodrigues, Alex Buko, Jon F. Denissen	1996	299
3	Pharmacokinetics of Lenalidomide in Subjects With Various Degrees of Renal Impairment and in Subjects on Hemodialysis The Journal of Clinical Pharmacology ·Nianhang Chen, Henry Lau, Linghui Kong, Gondi Kumar, Jerom B. Zeldis, Robert Knight, Osca L. Laskin	2007	202
4	Role of drug metabolism in drug discovery and development Medicinal Research Reviews ·Gondi Kumar, Sekhar Surapaneni	2001	157
5	Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus Virology ·Akhteruzzaman Molla, Sudthida Vasavanonda, Gondi Kumar, Hing L. Sham, Marianne K. Johnson, Brian Grabowski, Jon F. Denissen, William E. Kohlbrenner, Jacob J. Plattner, John M. Leonard, Daniel W. Norbeck, Dale J. Kempf	1998	154
6	Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction Drug Metabolism and Disposition ·Gondi Kumar, J.C. Dykstra, Ellen Roberts, Venkata Jayanti, Dean Hickman, John T. Uchic, Ye Yao, Bruce W. Surber, Samuel Thomas, G. Richard Granneman	1999	133
7	Taxol metabolism and disposition in cancer patients. Drug Metabolism and Disposition ·Thomas Walle, U. Kristina Walle, Gondi Kumar, Kapil N. Bhalla	1995	123
8	In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective Drug Metabolism and Disposition ·Valeria Chu, Heidi J. Einolf, Raymond Evers, Gondi Kumar, David D. Moore, Sharon L. Ripp, José Silva, Vikram Sinha, Michael Sinz, Andrej Skerjanec	2009	108
9	Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration Cancer Chemotherapy and Pharmacology ·Matthew Hoffmann, Claudia Kasserra, Josephine Reyes, Peter Schäfer, Jolanta Kosek, Lori Capone, Anastasia Parton, Heasook Kim‐Kang, Sekhar Surapaneni, Gondi Kumar	2012	98
10	Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans Pharmaceutical Research ·Gondi Kumar, Venkata Jayanti, Marianne K. Johnson, John T. Uchic, Samuel Thomas, Ronald Lee, Brian Grabowski, Hing L. Sham, Dale J. Kempf, Jon F. Denissen, Kennan C. Marsh, Eugene Sun, Stanley Roberts	2004	90
11	Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein. PubMed ·Gondi Kumar, U. Kristina Walle, Kapil N. Bhalla, Thomas Walle	1993	84
12	Cytochrome P450 3A-mediated human liver microsomal taxol 6 alpha-hydroxylation. Journal of Pharmacology and Experimental Therapeutics ·Gondi Kumar, U. Kristina Walle, Thomas Walle	1994	77
13	Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects Cancer Chemotherapy and Pharmacology ·Nianhang Chen, Lian Wen, Henry Lau, Sekhar Surapaneni, Gondi Kumar	2011	73
14	Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Modulator Drug Metabolism and Disposition ·Sekhar Surapaneni, Usha Yerramilli, April Bai, Deepak Dalvie, Jennifer L. Brooks, Xiaomin Wang, Julie V. Selkirk, Yingzhuo Yan, Peijin Zhang, Richard Hargreaves, Gondi Kumar, Maria Palmisano, Jonathan Q. Tran	2021	56
15	In Vitro Metabolism of the HIV-1 Protease Inhibitor ABT-378: Species Comparison and Metabolite Identification Drug Metabolism and Disposition ·Gondi Kumar, Venkata Jayanti, Ronald Lee, David N. Whittern, John T. Uchic, Samuel Thomas, PAULETTE JOHNSON, Brian Grabowski, Hing L. Sham, David A. Betebenner, Dale J. Kempf, Jon F. Denissen	1999	51
16	METABOLISM AND DISPOSITION OF CALCIMIMETIC AGENT CINACALCET HCL IN HUMANS AND ANIMAL MODELS Drug Metabolism and Disposition ·Gondi Kumar, Christopher D. Sproul, Leszek Poppe, S. Derek Turner, Mark Gohdes, Hesham Ghoborah, Desmond Padhi, Lorin Roskos	2004	48
17	Disposition, metabolism and mass balance of [¹⁴C]apremilast following oral administration Xenobiotica ·Matthew Hoffmann, Gondi Kumar, Peter Schäfer, Dorota Cedzik, Lori Capone, K L Fong, Zhe-ming Gu, Dennis Heller, Hao Feng, Sekhar Surapaneni, Oscar L. Laskin, Anfan Wu	2011	41
18	Comparative in vitro cytotoxic effects of taxol and its major human metabolite 6?-hydroxytaxol Cancer Chemotherapy and Pharmacology ·Gondi Kumar, Swapan K. Ray, Thomas Walle, Yue Huang, Mark C. Willingham, Sally Self, Kapil N. Bhalla	1995	36
19	Pomalidomide: Evaluation of cytochrome P450 and transporter-mediated drug-drug interaction potential in vitro and in healthy subjects The Journal of Clinical Pharmacology ·Claudia Kasserra, Mahmoud Assaf, Matthew Hoffmann, Yan Li, Liangang Liu, Xiaomin Wang, Gondi Kumar, Maria Palmisano	2014	31
20	6 alpha-Hydroxytaxol: isolation and identification of the major metabolite of taxol in human liver microsomes. Drug Metabolism and Disposition ·Gondi Kumar, John E. Oatis, K.R. Thornburg, F J Heldrich, E. Starr Hazard, Thomas Walle	1994	30

About Gondi Kumar

Gondi Kumar is a scholar working on Oncology, Molecular Biology, Pharmacology, Infectious Diseases and Hematology, having authored 53 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Pharmacogenetics and Drug Metabolism (13 papers), HIV/AIDS drug development and treatment (10 papers), Multiple Myeloma Research and Treatments (9 papers), Drug Transport and Resistance Mechanisms (9 papers), HIV Research and Treatment (6 papers), Protein Degradation and Inhibitors (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). The work is most often cited by research in Virology (523 citations), Pharmacology (654 citations), Infectious Diseases (826 citations), Hematology (425 citations) and Oncology (894 citations). Gondi Kumar has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Sekhar Surapaneni, Jon F. Denissen, Thomas Walle, U. Kristina Walle, A. David Rodrigues, Alex Buko, Kapil N. Bhalla, Henry Lau, Nianhang Chen and Dale J. Kempf. Their work appears in journals such as Drug Metabolism and Disposition, Cancer Chemotherapy and Pharmacology, Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics and Xenobiotica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact